The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysisMaarten M.J. Wijnenga, Martin J. van den Bent, Geert‐Jan Rutten et al.|Neuro-Oncology|2017Cited by 330
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteriaC. Mircea S. Tesileanu, Martin J. van den Bent, Hendrikus J. Dubbink et al.|Neuro-Oncology|2019Cited by 213